What is Vumerity?
Vumeriti (dimethyl fumarate) is an oral medication used to treat relapsing forms of multiple sclerosis (MS) in adults [1]. It is a fumaric acid ester [2].
How does Vumerity work for MS?
The precise mechanism by which Vumeriti exerts its therapeutic effects in multiple sclerosis is not fully understood [1]. However, it is believed to involve the activation of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) antioxidant response pathway [1][2]. This pathway plays a role in protecting cells from oxidative stress and inflammation, both of which are implicated in MS [2].
What are the approved uses of Vumeriti?
Vumeriti is approved for the treatment of relapsing forms of multiple sclerosis in adults [1]. This includes clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS [3].
When does Vumeriti's patent expire?
Information regarding the patent expiry for Vumeriti can be found on DrugPatentWatch.com [4].
Who makes Vumeriti?
Vumeriti is manufactured by Biogen [1].
What are common side effects of Vumeriti?
Common side effects of Vumeriti include flushing, gastrointestinal issues such as nausea, vomiting, and diarrhea, and a decrease in lymphocyte count [1].
What clinical trials support Vumeriti's use?
Vumeriti's efficacy was demonstrated in two Phase 3 clinical trials, Defining the Efficacy and Safety of Vumeriti (NCT01917798) and Placebo-Controlled Study of Oral Vumeriti (NCT01917798) [3]. These trials evaluated Vumeriti compared to placebo in patients with relapsing MS [3].
How does Vumeriti compare to other MS treatments?
Vumeriti is one of several disease-modifying therapies available for relapsing forms of MS. Other treatments include injectables like interferon beta-1a and glatiramer acetate, as well as other oral medications such as fingolimod and teriflunomide [5]. The choice of treatment depends on individual patient factors, disease activity, and physician recommendation [5].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/
[5] https://www.drugpatentwatch.com/